Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCarfilzomib weekly 20/56 mg/m<sup>2</sup>, lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.AuthorsRichez, Valentine; Gruchet, Cecile; Guidez, Stephanie; Fouquet, Guillemette; Azais, Isabelle; Durand, Geraldine; Javaugue, Vincent; Brigaud, Antoine; Plasse, Florent; Diolez, Jéremie; Machet, Antoine; Moya, Niels; Gardeney, Helene; Franques, Paul; Bobin, Arthur; Levy, Anthony; Sabirou, Florence; Bonnin, Anthony; Dieval, Celine; Primault, SylvainPublicationAmerican Journal of Hematology, 2019, Vol 94, Issue 1, pE17ISSN0361-8609Publication typeArticleDOI10.1002/ajh.25327